FDA alarms on birth-control pills as a high risk of blood clot formation

The United States Food and Drug Administration (FDA)—“remains concerned” over certain contraceptive pills that includes “drospirenone” that might raise a high risk of blood clots.

     

During a drug safety announcement on the agencies webpage, in the preliminary study Food and Drug Administration (FDA), founded a result suggests an increase of 1.5-fold threat of blood clots in the women who use birth control pills containing Bayer, as compared to the users of other hormonal birth control pills.

Bayer best selling drug, generic Yasmin and generic Yaz includes “drospirenone” that is a sort of sex hormone in females known as progestin, also accessible in it generic form.

Food and Drug Administration (FDA), has still not reached to a conclusion, weather only these products have a high risk of developing blood clots over the other pills. FDA has set up a external board of medical experts to talk about the issue.

Nearly all the contraceptive pills include 2 types of hormones progestin and estrogen. Hence all the pills raise a risk of blood clots and contain a warning label.

But according to FDA there is contradicting information over the risk of blood clot; most probably it is linked with drospirenone. Apart from this, there are six other studies published over the blood clot risk. Like some have reported that the formation blood clot is due to the used of drospirenone in the pills where as some say, use of levonorgestrel in the birth control pills also have the same risk. Whereas the risk of blood-clots is less among those women who intake birth-control medicine, the Food and Drug Administration (FDA) suggests that women’s who aren't consuming these pills are at the higher risk.